Too little does not work. Too much causes harm. PainIQ gives chronic pain patients the clinical precision, plain language, and real answers their medications deserve.
Select your medication, diagnosis, and current situation. Get a physician-designed schedule built around where you are right now. Currently covering gabapentin, Lyrica, and low dose naltrexone — with more medications coming soon.
Select your diagnosis to learn how gabapentin and Lyrica work for your specific condition.
Post-herpetic neuralgia (PHN) occurs when the shingles virus damages nerve fibers, causing them to send abnormal pain signals long after the rash resolves. Both gabapentin and Lyrica directly target this overactive nerve firing.
What patients are rarely told: Most patients with PHN require 1,200–1,800mg/day of gabapentin or 300–600mg/day of Lyrica for meaningful relief. PHN pain frequently peaks at night — a heavier bedtime dose is essential.
Gabapentin: Titrate over 4–8 weeks toward 1,200–1,800mg/day. Nighttime dose intentionally heaviest.
Lyrica: FDA-approved for PHN. Therapeutic range 300–600mg/day. More predictable absorption.
Sciatica is nerve pain — not muscular pain. Standard pain medications like ibuprofen often provide little relief because they target inflammation, not nerve signaling. Gabapentin and Lyrica are mechanistically appropriate because they reduce the abnormal firing of the compressed sciatic nerve.
The most common failure point: Patients are started at doses far too low to reach the sciatic nerve pathway effectively. Therapeutic doses for sciatica often require a careful ramp to 900–1,800mg/day.
Gabapentin: Three times daily dosing essential. Titrate toward 900–1,800mg/day over 4–8 weeks.
Lyrica: Twice daily sufficient. 150–450mg/day typical therapeutic range.
These medications reduce nerve pain signals — they do not decompress the nerve or fix the underlying disc or stenosis. They work best as part of a comprehensive plan with physical therapy or injections.
Fibromyalgia is a disorder of central sensitization — the brain amplifies pain signals. Lyrica received FDA approval specifically for fibromyalgia in 2007. Gabapentin is also widely used off-label. Both calm the overactive central nervous system that drives fibromyalgia pain.
Sleep is central: The sedating effect of these medications at bedtime is not a side effect to minimize — it is a therapeutic tool. The nighttime dose should always be the largest.
Lyrica (preferred): FDA-approved. Start at 75mg twice daily, titrate to 300–450mg/day. Evening dose largest.
Gabapentin: Effective alternative. Titrate to 1,200–2,400mg/day. Bedtime dose heaviest.
Weight gain is more pronounced with Lyrica — particularly relevant for fibromyalgia patients. Discuss proactively with your physician from the start.
Diabetic peripheral neuropathy affects up to 50% of people with diabetes. High blood sugar damages small nerve fibers, causing burning, tingling, numbness, or stabbing pain — most commonly in the feet and legs. Both gabapentin and Lyrica are first-line treatments.
Foot and leg pain is worst at night for most DPN patients. A heavily weighted bedtime dose targets the peak pain window and improves sleep simultaneously.
Lyrica (FDA-approved for DPN): 150–600mg/day in 2–3 divided doses. Evening dose largest.
Gabapentin: Effective, less costly. Titrate to 900–1,800mg/day. Bedtime dose heaviest.
Gabapentin and Lyrica-related edema can be more pronounced in diabetic patients. Monitor ankle and foot swelling and report significant changes to your physician.
Radiculopathy occurs when a nerve root in the spine is compressed, sending pain, numbness, or tingling along the nerve path. The radiating quality of this pain indicates nerve involvement — precisely what gabapentin and Lyrica are designed to treat.
Under-dosing is the rule: Radiculopathy patients consistently require 900–1,800mg/day of gabapentin for meaningful nerve pain relief. Starting at 300mg/day and staying there is almost universally insufficient.
Gabapentin: Three times daily essential. Titrate toward 900–1,800mg/day over 4–8 weeks.
Lyrica: Twice daily sufficient. 150–450mg/day typical. More predictable blood levels.
Epidural steroid injections can provide significant short-term relief and work well alongside oral nerve pain medications. Physical therapy addresses the underlying mechanical issues.
Peripheral neuropathy describes damage to the nerves outside the brain and spinal cord. Causes include diabetes, chemotherapy, alcohol, autoimmune disease, and idiopathic origins. Gabapentin and Lyrica calm the abnormal nerve signaling at the source.
Consistency is non-negotiable. Neuropathic pain requires stable, round-the-clock medication levels. As-needed use provides no meaningful benefit. The bedtime dose should always be the largest.
Gabapentin: Three times daily. Titrate to 900–3,600mg/day. Bedtime dose consistently largest.
Lyrica: Twice daily. 150–600mg/day. Often preferred for patients who found gabapentin inconsistent.
Before long-term medication, your physician should evaluate the underlying cause. Treatable causes include B12 deficiency, thyroid disorders, and autoimmune conditions.
The PainIQ AI assistant is built on physician protocols covering gabapentin and Lyrica — dosing, side effects, tapering, misconceptions, and more.
The clinical knowledge every gabapentin and Lyrica patient deserves — in plain language.
Gabapentin and Lyrica are not as-needed medications. They stabilize overactive nerve signaling — a process requiring consistent blood levels built up over days to weeks. Taking them only when pain spikes provides little benefit. They must be taken on a fixed schedule, typically 2–3 times daily.
Most patients stop within the first week because nothing seems to be happening. Meaningful nerve pain relief typically requires 2–4 weeks at a consistent therapeutic dose. The first 1–2 weeks are for building tolerance, not achieving pain relief.
Abrupt discontinuation causes withdrawal — anxiety, insomnia, sweating, nausea, and rebound pain. At high doses, stopping suddenly can cause seizures. Always taper gradually under physician supervision, reducing by 10–25% every 1–2 weeks.
Both medications significantly amplify the effects of alcohol, benzodiazepines, and other CNS depressants. This combination can cause dangerous respiratory depression. The combined sedation effect is not additive — it is multiplicative. Do not combine without explicit physician guidance.
Gabapentin's absorption decreases at higher single doses. Three-times-daily dosing is far more effective than one large daily dose. If gabapentin "didn't work," the dosing schedule — not the drug — may have been the problem.
Starting doses of 100–300mg/day exist to minimize early side effects, not to treat pain. Many patients require 600mg three times daily — 1,800mg total — before experiencing meaningful nerve pain relief. The starting dose is a ramp, not a destination.
| Feature | Gabapentin | Lyrica (Pregabalin) |
|---|---|---|
| Absorption | Variable — decreases at higher doses | Predictable — linear at all doses |
| Optimal dosing | 3× daily essential | 2–3× daily sufficient |
| Dose range | 300–3,600mg/day | 150–600mg/day |
| Controlled status | Schedule V in some states only | Schedule V federally |
| Cost | Generic — very affordable | Higher cost (generic available) |
| Weight gain | Moderate | More pronounced |
| Best for | Cost-sensitive, first-line patients | Predictable dosing, fibromyalgia |
Search PubMed, NEJM, JAMA, The Lancet, BMJ, and WSJ Health — curated for gabapentin, Lyrica, and pain management research.
PainIQ Member gives you the education every patient deserves. PainIQ Pro gives you your own AI physician — available 24/7 for $8/month.